Biocardia initiates patient enrollment at emory university school of medicine for ongoing cardiamp hf ii pivotal study

Cardiamp hf ii is evaluating the cardiamp™ cell therapy product for treating patients with ischemic heart failure of reduced ejection fraction and elevated markers of cardiac stress
BCDA Ratings Summary
BCDA Quant Ranking